Opioid agonist / antagonist combination dosage forms

The presently disclosed subject matter provides a solid, immediate release, pharmaceutical multi-particulate dosage form containing at least one population of Opioid Particulates comprising one or more opioids; at least one population of Naloxone Particulates; and a population of Triggering Particul...

Full description

Saved in:
Bibliographic Details
Main Authors Desai, Dipen, Thongsukmak, Atsawin, Phuapradit, Wantanee, Sandhu, Harpreet Kaur, Patel, Chanchal, Tiwari, Roshan V, Shah, Navnit H, Vaka, Siva Ram Kiran
Format Patent
LanguageEnglish
Published 30.03.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The presently disclosed subject matter provides a solid, immediate release, pharmaceutical multi-particulate dosage form containing at least one population of Opioid Particulates comprising one or more opioids; at least one population of Naloxone Particulates; and a population of Triggering Particulates. Each population of particulates is designed for a specific function to accomplish the desired combination of abuse deterrence and overdose protection.
AbstractList The presently disclosed subject matter provides a solid, immediate release, pharmaceutical multi-particulate dosage form containing at least one population of Opioid Particulates comprising one or more opioids; at least one population of Naloxone Particulates; and a population of Triggering Particulates. Each population of particulates is designed for a specific function to accomplish the desired combination of abuse deterrence and overdose protection.
Author Phuapradit, Wantanee
Shah, Navnit H
Patel, Chanchal
Vaka, Siva Ram Kiran
Tiwari, Roshan V
Thongsukmak, Atsawin
Desai, Dipen
Sandhu, Harpreet Kaur
Author_xml – fullname: Desai, Dipen
– fullname: Thongsukmak, Atsawin
– fullname: Phuapradit, Wantanee
– fullname: Sandhu, Harpreet Kaur
– fullname: Patel, Chanchal
– fullname: Tiwari, Roshan V
– fullname: Shah, Navnit H
– fullname: Vaka, Siva Ram Kiran
BookMark eNrjYmDJy89L5WQw8S_IzM9MUUhMz8_LLC5R0FdIzCuBcZLzc5My8xJLMvPzFFLyixPTUxXS8otyi3kYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBpZmBgYGhk5ExMWoALKUunA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10960001B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10960001B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:02:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10960001B23
Notes Application Number: US201816477268
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210330&DB=EPODOC&CC=US&NR=10960001B2
ParticipantIDs epo_espacenet_US10960001B2
PublicationCentury 2000
PublicationDate 20210330
PublicationDateYYYYMMDD 2021-03-30
PublicationDate_xml – month: 03
  year: 2021
  text: 20210330
  day: 30
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies KASHIV PHARMA LLC
KASHIV BIOSCIENCES, LLC
RelatedCompanies_xml – name: KASHIV BIOSCIENCES, LLC
– name: KASHIV PHARMA LLC
Score 3.3207045
Snippet The presently disclosed subject matter provides a solid, immediate release, pharmaceutical multi-particulate dosage form containing at least one population of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Opioid agonist / antagonist combination dosage forms
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210330&DB=EPODOC&locale=&CC=US&NR=10960001B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVdH6YAXJbWmNeWwOQciLIrQptpHeyqZJJB6SYCL9-51dEutFb_uA3cnAzHzfZmcW4JGpGTJpblJupZxqpmlRUf2Uaio3DT3GCJ-J847pzJhE2utKX_Xgs8uFkXVCt7I4IlrUBu29kf662h9iefJuZT2KcxwqX4Kl7SktO0b-gvxc8Rzbn4de6Cqua0cLZfaGWBehOrpkB931AcJoU1iD_-6IrJTqd0gJTuFwjqsVzRn00mIAx2738toAjqbtD29strZXn4MWVnmZJ4R_lKLaLRkRVErXQeGR4krBSVKKy2JEoNH6Ah4Cf-lOKG6__vnWdbTYS_p8Cf2iLNIrIJm6UcdpwnWLI6HTufWkxZwxg1kZQ0gRX8Pw73WG_03ewInQm0yzG99Cv_n6Tu8wzjbxvVTQDpEqgNc
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVaX5gYbqQVeR6ICa-gFmgsmN7I0oLBAxDB-Ped3YD1ord9JLvDJDPzfcvOLMCtJubIpIkqED0jgqSqukCrnwqSSFRFTjHC5_S8ww8UL5aeVvJqAO99LgyrE_rFiiOiRa3R3lvmr-vtIZbN7lY207TAoerBjQyb79gx8hfk57xtGs4itEOLtywjXvLBC2JdhOrokk101zsIsVVqDc6rSbNS6t8hxT2A3QWuVraHMMjKMYys_uW1Mez53Q9vbHa21xyBFNZFVWw48lbRarfclEOl9B0UHikuE5zbVPSyGEfRaHMMN64TWZ6A2yc_35rEy62k9ycwLKsyOwUuF9fiLNsQWSdI6GSi30kp0TRF03MNIUV6BpO_15n8N3kNIy_y58n8MXg-h32qQ5ZyN7uAYfvxmV1izG3TK6asb8eLg8o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Opioid+agonist+%2F+antagonist+combination+dosage+forms&rft.inventor=Desai%2C+Dipen&rft.inventor=Thongsukmak%2C+Atsawin&rft.inventor=Phuapradit%2C+Wantanee&rft.inventor=Sandhu%2C+Harpreet+Kaur&rft.inventor=Patel%2C+Chanchal&rft.inventor=Tiwari%2C+Roshan+V&rft.inventor=Shah%2C+Navnit+H&rft.inventor=Vaka%2C+Siva+Ram+Kiran&rft.date=2021-03-30&rft.externalDBID=B2&rft.externalDocID=US10960001B2